Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 

Online Report Subscribers, Click Here
Pricing and Ordering Information

  

U.S. Markets for Percutaneous Vertebroplasty and Vertebral Augmentation Products and Thermal Intradiscal Devices
Report #A337 - October 2012
139 Pages – 40 Exhibits – 5 Company Profiles

Back pain is one of the most common medical problems in the United States (U.S.), affecting 8 out of 10 people at some point during their lives. Degeneration of an intervertebral disc that results in functionally limiting low back pain is a common condition that prompts patients to seek treatment. For the appropriate patient subset, a percutaneous thermal intradiscal procedure may be employed to treat chronic low back pain. In addition, vertebral compression fractures are a leading cause of disability and morbidity in the elderly population; elderly patients with collapsed vertebrae due to osteoporosis have an impaired ability to heal and may suffer severe spinal deformity. Vertebroplasty and vertebral augmentation or kyphoplasty are minimally invasive techniques used to treat symptomatic vertebral compression fractures resulting from osteoporosis and certain metastatic tumors.

The combined U.S. market for percutaneous vertebroplasty and vertebral augmentation products and thermal intradiscal devices is projected to increase at a compound annual rate of 2.5% during the forecast period covered by this report (from 2011 to 2016).

This dynamic new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the area of percutaneous vertebroplasty and vertebral augmentation products and thermal intradiscal devices. The market segments that are covered by this report include percutaneous vertebroplasty and kyphoplasty systems and thermal intradiscal devices (including nucleoplasty and intradiscal biacuplasty and electrothermal therapy products).

Ordering Information

Title

 Report# Publication
Date		 List Price

U.S. Markets for Percutaneous Vertebroplasty and Vertebral Augmentation Products and Thermal Intradiscal Devices

A337

October 2012

$3,750
Order Online:
Single User only (Please call for corporate subscription pricing)		 PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

EXECUTIVE SUMMARY

i.      Selected Spinal Disorders

a.     Degenerative Disc Disease

b.     Disc Herniation

c.     Spinal Tumors

d.     Traumatic Spinal Injuries

e.     Vertebral Fractures

ii.     Percutaneous Vertebroplasty and Vertebral Augmentation Products Market

a.     Market Analysis

iii.    Percutaneous Thermal Intradiscal Products Market

a.     Intradiscal Biacuplasty

b.     Intradiscal Electrothermal Therapy

c.     Plasma Disc Decompression

d.     Market Analysis

iv.    Combined Market Forecast

v.     Methodology

 

Exhibit ES-1:    Prevalence of Selected Spinal Disorders, 2011-2016

Exhibit ES-2:    Incidence of Selected Spinal Disorders, 2011-2016

Exhibit ES-3:    Vertebroplasty and Vertebral Augmentation Products, Market Forecast, 2011-2016

Exhibit ES-4:    Percutaneous Thermal Intradiscal Products, Market Forecast, 2011-2016

Exhibit ES-5:    Percutaneous Vertebroplasty/Vertebral Augmentation and Thermal Intradiscal Products, Combined Market Forecast, 2011-2016

 

1. CLINICAL OVERVIEW

1.1 The Human Spine

1.2 Bone Structure and Function

1.2.1 Bone Formation

1.2.2 Cellular Framework

1.2.2.1 Osteoblasts

1.2.2.2 Osteocytes

1.2.2.3 Osteoclasts

1.2.3 The Fracture Healing Process

1.2.4 Factors Affecting Bone Physiology

1.2.4.1 The Effect of Physical Stress on Bone Remodeling 

1.2.4.2 Age and Gender

1.2.4.3 Physical Activity

1.2.4.4 Obesity

1.2.4.5 Cigarette Smoking, Alcohol, and Caffeine

1.2.4.6 Nutritional Deficiencies

1.3 Selected Spinal Disorders

1.3.1 Disc Herniation

1.3.2 Degenerative Disc Disease

1.3.2.1 Arthritis

1.3.2.1.1 Osteoarthritis

1.3.2.1.2 Rheumatoid Arthritis

1.3.2.1.3 Ankylosing Spondylitis

1.3.2.2 Osteoporosis

1.3.2.3 Spondylosis

1.3.3 Abnormal Curvature of the Spine

1.3.3.1 Scoliosis

1.3.3.2 Kyphosis and Lordosis

1.3.4 Spondylolisthesis

1.3.5 Stenosis

1.3.6 Spinal Tumors

1.3.7 Traumatic Spinal Injuries

1.3.8 Vertebral Fractures

1.4 Spine Treatment Options

1.4.1 Spinal Decompression

1.4.1.1 Corpectomy

1.4.1.2 Discectomy

1.4.1.3 Facetectomy

1.4.1.4 Foraminotomy/Foraminectomy

1.4.1.5 Laminotomy/Laminectomy

1.4.2 Spinal Fusion

1.4.2.1 Instrumented versus Noninstrumented Spinal Fusion

1.4.2.1.1 Instrumented Spinal Fusion

1.4.2.1.2 Noninstrumented Spinal Fusion

1.4.2.2 Types of Fusion

1.4.2.2.1 Cervical Fusion

1.4.2.2.2 Anterior Cervical Fusion

1.4.2.2.3 Posterior Cervical Fusion

1.4.2.2.4 Interbody Fusion

1.4.2.2.5 Lumbar Fusion

1.4.2.2.5.1 Anterior Lumbar Interbody Fusion

1.4.2.2.5.2 Posterior Lumbar Interbody Fusion

1.4.2.2.5.3 Transforaminal Lumbar Interbody Fusion

1.4.2.2.6 Posterolateral Fusion

1.4.2.2.7 360-Degree Fusion

1.4.2.2.8 Thoracic and Thoracolumbar Fusion

1.4.2.2.9 Percutaneous or Minimally Invasive Fusion

1.4.3 Posterior Dynamic Stabilization

1.5 Market Dynamics

1.5.1 Demographics

1.5.2 Reimbursement

1.5.3 Patient Protection and Affordable Care Act

1.5.4 Federal Oversight of Physician/Corporate Relationships

1.5.5 Procedure Volumes Forecast

 

Exhibit 1-1:      The Human Spine

Exhibit 1-2:      The Structure of Collagen

Exhibit 1-3:      The Structure of Hydroxyapatite

Exhibit 1-4:      The Structure of Bone

Exhibit 1-5:      Bone Density Averages in the General Population

Exhibit 1-6:      Bone Density Averages in Olympic Athletes in Comparison with the General Population

Exhibit 1-7:      Number of Overweight and Obese People, 2011 and 2016

Exhibit 1-8:      A Herniated Disc

Exhibit 1-9:      Bone Density in Normal and Osteoporotic Bone Tissue

Exhibit 1-10:    Prevalence of Selected Spinal Disorders, 2011-2016

Exhibit 1-11:    Incidence of Selected Spinal Disorders, 2011-2016

Exhibit 1-12:    The Anatomy of a Spinal Segment

Exhibit 1-13:    Noninstrumented Spinal Fusion

Exhibit 1-14:    United States Population Growth Trends

Exhibit 1-15:    Spinal Fusion Diagnosis-Related Groups and Associated Medicare Reimbursement

Exhibit 1-16:    Spinal Fusion, Procedure Volumes Forecast, 2010-2016

 

2. PERCUTANEOUS VERTEBROPLASTY AND VEREBRAL AUGMENTATION PRODUCTS MARKET

2.1 Vertebroplasty

2.1.1 Polymethylmethacrylate Alternatives

2.2 Kyphoplasty

2.3 Technology Assessments

2.4 Reimbursement

2.5 Vertebroplasty Products

2.6 Percutaneous Vertebral Augmentation Products

2.6.1 Emerging Vertebral Augmentation Products

2.7 Market Analysis

2.8 Competitive Analysis

 

Exhibit 2-1:      The Vertebroplasty Procedure

Exhibit 2-2:      Vertebroplasty Indications and Contraindications

Exhibit 2-3:      The Balloon Kyphoplasty Procedure

Exhibit 2-4:      2012, Percutaneous Vertebroplasty, Medicare Physician Reimbursement

Exhibit 2-5:      2012, Percutaneous Vertebral Augmentation, Medicare Physician Reimbursement

Exhibit 2-6:      2012, Percutaneous Vertebral Augmentation and Percutaneous Vertebroplasty, Medicare Hospital Inpatient, Possible MS-DRG Groups

Exhibit 2-7:      2012, Percutaneous Vertebroplasty, Medicare Hospital Outpatient and Ambulatory Surgery Center Reimbursement

Exhibit 2-8:      2012, Percutaneous Vertebral Augmentation, Medicare Hospital Outpatient and Ambulatory Surgery Center Reimbursement

Exhibit 2-9:      2012, Selected Vertebroplasty Products

Exhibit 2-10:    2012, Selected Percutaneous Vertebral Augmentation Products

Exhibit 2-11:    2012, Selected Emerging Vertebroplasty and Vertebral Augmentation Products

Exhibit 2-12:    Vertebroplasty and Vertebral Augmentation Products, Market Forecast, 2011-2016

Exhibit 2-13:    2011, Vertebroplasty and Vertebral Augmentation Products Market, Share by Supplier

 

3. PERCUTANEOUS THERMAL INTRADISCAL PRODUCTS MARKET

3.1 Intradiscal Annuloplasty

3.1.1 Intradiscal Biacuplasty

3.1.2 Intradiscal Electrothermal Therapy

3.2 Plasma Disc Decompression

3.3 Clinical Trials

3.3.1 Intradiscal Biacuplasty

3.3.2 Intradiscal Electrothermal Therapy

3.3.3 Nucleoplasty

3.4 Reimbursement

3.5 Emerging Technology

3.6 Market Analysis

3.7 Competitive Analysis

 

Exhibit 3-1:      Intradiscal Biacuplasty Using the TransDiscal System

Exhibit 3-2:      The SpineCath Intradiscal Catheter

Exhibit 3-3:      The Plasma Disc Decompression Procedure

Exhibit 3-4:      2012, Selected Percutaneous Thermal Intradiscal Products

Exhibit 3-5:      Percutaneous Thermal Intradiscal Products,  Market Forecast, 2011-2016

Exhibit 3-6:      2011, Percutaneous Thermal Intradiscal Products Market, Share by Supplier

 

4. COMPANY PROFILES

4.1       ArthroCare Corporation

4.2       CareFusion Corporation

4.3       Medtronic, Inc.

4.4       NeuroTherm, Inc.

4.5       Stryker Corporation

 

APPENDIX: COMPANY LISTING

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact reports@elsevier.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home